| 0 |
SUCROSE INTOLERANCE |
1 |
0.0294 |
| 1 |
GASTRIC HYPERMOTILITY |
1 |
0.0250 |
| 2 |
ALEXITHYMIA |
1 |
0.0200 |
| 3 |
SMALL INTESTINAL BACTERIAL OVERGROWTH |
1 |
0.0169 |
| 4 |
ANAL INJURY |
1 |
0.0058 |
| 5 |
URETHRITIS NONINFECTIVE |
1 |
0.0040 |
| 6 |
OESOPHAGEAL FOOD IMPACTION |
1 |
0.0018 |
| 7 |
RENAL TUBULAR DYSFUNCTION |
1 |
0.0018 |
| 8 |
BONE OPERATION |
1 |
0.0015 |
| 9 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 10 |
DERMATITIS DIAPER |
1 |
0.0014 |
| 11 |
DIET REFUSAL |
1 |
0.0014 |
| 12 |
VITAMIN B12 INCREASED |
1 |
0.0013 |
| 13 |
SYSTEMIC LUPUS ERYTHEMATOSUS RASH |
1 |
0.0013 |
| 14 |
BLOOD UREA ABNORMAL |
1 |
0.0011 |
| 15 |
INTUSSUSCEPTION |
1 |
0.0010 |
| 16 |
DYSPLASIA |
1 |
0.0008 |
| 17 |
PRODUCT COLOUR ISSUE |
4 |
0.0008 |
| 18 |
DARK CIRCLES UNDER EYES |
1 |
0.0007 |
| 19 |
OSTEOMALACIA |
1 |
0.0006 |
| 20 |
PRODUCT TASTE ABNORMAL |
8 |
0.0006 |
| 21 |
MILIARIA |
1 |
0.0006 |
| 22 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 23 |
PANCREATIC FAILURE |
1 |
0.0006 |
| 24 |
BREAST CYST |
1 |
0.0006 |
| 25 |
TERMINAL INSOMNIA |
1 |
0.0006 |
| 26 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 27 |
LIQUID PRODUCT PHYSICAL ISSUE |
3 |
0.0004 |
| 28 |
DRUG TITRATION ERROR |
1 |
0.0004 |
| 29 |
LIPOMA |
1 |
0.0004 |
| 30 |
FLATULENCE |
17 |
0.0003 |
| 31 |
REGURGITATION |
1 |
0.0003 |
| 32 |
LIP OEDEMA |
1 |
0.0002 |
| 33 |
URINE ABNORMALITY |
1 |
0.0002 |
| 34 |
PULSE ABSENT |
1 |
0.0002 |
| 35 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 36 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 37 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 38 |
CHEILITIS |
1 |
0.0002 |
| 39 |
FAECALOMA |
1 |
0.0002 |
| 40 |
ABDOMINAL DISTENSION |
19 |
0.0002 |
| 41 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 42 |
THIRST |
3 |
0.0002 |
| 43 |
CARDIAC PACEMAKER INSERTION |
1 |
0.0002 |
| 44 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 45 |
PROCTALGIA |
1 |
0.0002 |
| 46 |
ABDOMINAL PAIN |
35 |
0.0002 |
| 47 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 48 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 49 |
ORAL DISCOMFORT |
2 |
0.0001 |
| 50 |
FAECES SOFT |
1 |
0.0001 |
| 51 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 52 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 53 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 54 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 55 |
GROIN PAIN |
1 |
0.0001 |
| 56 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 57 |
THROAT IRRITATION |
5 |
0.0001 |
| 58 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 59 |
FLANK PAIN |
1 |
0.0001 |
| 60 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 61 |
ERUCTATION |
2 |
0.0001 |
| 62 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 63 |
EAR DISCOMFORT |
1 |
0.0001 |
| 64 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 65 |
POLLAKIURIA |
4 |
0.0001 |
| 66 |
PETECHIAE |
1 |
0.0001 |
| 67 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 68 |
INCONTINENCE |
1 |
0.0001 |
| 69 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 70 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 71 |
TOOTH FRACTURE |
1 |
0.0001 |
| 72 |
DENTAL CARIES |
1 |
0.0001 |
| 73 |
MALNUTRITION |
1 |
0.0001 |
| 74 |
EYE INFECTION |
1 |
0.0001 |
| 75 |
PRODUCT QUALITY ISSUE |
12 |
0.0001 |
| 76 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 77 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 78 |
ACCIDENT |
1 |
0.0001 |
| 79 |
BLOOD PRESSURE FLUCTUATION |
2 |
0.0001 |
| 80 |
SPINAL OPERATION |
1 |
0.0001 |
| 81 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 82 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 83 |
HYPOPHAGIA |
2 |
0.0001 |
| 84 |
MYDRIASIS |
1 |
0.0001 |
| 85 |
RASH GENERALISED |
2 |
0.0001 |
| 86 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 87 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 88 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 89 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 90 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 91 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 92 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
1 |
0.0001 |
| 93 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 94 |
BONE LOSS |
1 |
0.0001 |
| 95 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 96 |
OSTEOPENIA |
1 |
0.0001 |
| 97 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 98 |
INSURANCE ISSUE |
1 |
0.0001 |
| 99 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 100 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 101 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 102 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 103 |
FUNGAL INFECTION |
2 |
0.0001 |
| 104 |
SYRINGE ISSUE |
1 |
0.0001 |
| 105 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 106 |
DIARRHOEA |
36 |
0.0001 |
| 107 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 108 |
EYE PAIN |
3 |
0.0001 |
| 109 |
FRACTURE |
1 |
0.0001 |
| 110 |
INCREASED APPETITE |
1 |
0.0001 |
| 111 |
GLAUCOMA |
1 |
0.0001 |
| 112 |
DYSTONIA |
1 |
0.0001 |
| 113 |
WHEEZING |
3 |
0.0001 |
| 114 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 115 |
TASTE DISORDER |
1 |
0.0000 |
| 116 |
OSTEOPOROSIS |
2 |
0.0000 |
| 117 |
RETCHING |
1 |
0.0000 |
| 118 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 119 |
GLOSSODYNIA |
1 |
0.0000 |
| 120 |
ORAL PAIN |
1 |
0.0000 |
| 121 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 122 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 123 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 124 |
THERAPY CESSATION |
2 |
0.0000 |
| 125 |
NERVOUSNESS |
2 |
0.0000 |
| 126 |
DEHYDRATION |
5 |
0.0000 |
| 127 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 128 |
JAUNDICE |
1 |
0.0000 |
| 129 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 130 |
CONSTIPATION |
8 |
0.0000 |
| 131 |
MOOD ALTERED |
1 |
0.0000 |
| 132 |
SKIN LESION |
1 |
0.0000 |
| 133 |
URTICARIA |
6 |
0.0000 |
| 134 |
ANGINA PECTORIS |
1 |
0.0000 |
| 135 |
LETHARGY |
2 |
0.0000 |
| 136 |
NEEDLE ISSUE |
1 |
0.0000 |
| 137 |
PALPITATIONS |
4 |
0.0000 |
| 138 |
INSOMNIA |
9 |
0.0000 |
| 139 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 140 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 141 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 142 |
OSTEONECROSIS |
1 |
0.0000 |
| 143 |
DECREASED APPETITE |
7 |
0.0000 |
| 144 |
LIP SWELLING |
1 |
0.0000 |
| 145 |
RASH MACULAR |
1 |
0.0000 |
| 146 |
CRYING |
1 |
0.0000 |
| 147 |
RESTLESSNESS |
1 |
0.0000 |
| 148 |
MUSCLE SPASMS |
5 |
0.0000 |
| 149 |
DYSARTHRIA |
1 |
0.0000 |
| 150 |
NAUSEA |
21 |
0.0000 |
| 151 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 152 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 153 |
ERYTHEMA |
5 |
0.0000 |
| 154 |
VOMITING |
11 |
0.0000 |
| 155 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 156 |
ANGIOEDEMA |
1 |
0.0000 |
| 157 |
TACHYCARDIA |
2 |
0.0000 |
| 158 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 159 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 160 |
DIZZINESS |
11 |
0.0000 |
| 161 |
SKIN IRRITATION |
1 |
0.0000 |
| 162 |
WEIGHT DECREASED |
6 |
0.0000 |
| 163 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 164 |
SWELLING |
2 |
0.0000 |
| 165 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 166 |
DYSPHAGIA |
2 |
0.0000 |
| 167 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 168 |
RENAL CANCER |
1 |
0.0000 |
| 169 |
MIGRAINE |
2 |
0.0000 |
| 170 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 171 |
DYSPEPSIA |
2 |
0.0000 |
| 172 |
HEART RATE INCREASED |
2 |
0.0000 |
| 173 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 174 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 175 |
ILLNESS |
2 |
0.0000 |
| 176 |
HEADACHE |
12 |
0.0000 |
| 177 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 178 |
DEPENDENCE |
1 |
0.0000 |
| 179 |
PRURITUS |
7 |
0.0000 |
| 180 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 181 |
INFLUENZA |
2 |
0.0000 |
| 182 |
SEPSIS |
2 |
0.0000 |
| 183 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 184 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 185 |
EYE IRRITATION |
1 |
0.0000 |
| 186 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 187 |
SEIZURE |
2 |
0.0000 |
| 188 |
NASAL CONGESTION |
1 |
0.0000 |
| 189 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |
| 190 |
CATARACT |
1 |
0.0000 |
| 191 |
DRUG INEFFECTIVE |
22 |
0.0000 |
| 192 |
IRRITABILITY |
1 |
0.0000 |
| 193 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 194 |
CHEST PAIN |
3 |
0.0000 |
| 195 |
RASH |
7 |
0.0000 |
| 196 |
AMNESIA |
1 |
0.0000 |
| 197 |
SWELLING FACE |
1 |
0.0000 |
| 198 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 199 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 200 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 201 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 202 |
BURNING SENSATION |
1 |
0.0000 |
| 203 |
SLEEP DISORDER |
1 |
0.0000 |
| 204 |
AGITATION |
1 |
0.0000 |
| 205 |
DYSGEUSIA |
1 |
0.0000 |
| 206 |
WEIGHT INCREASED |
3 |
0.0000 |
| 207 |
EPISTAXIS |
1 |
0.0000 |
| 208 |
HYPOAESTHESIA |
2 |
0.0000 |
| 209 |
HOT FLUSH |
1 |
0.0000 |
| 210 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 211 |
DEPRESSION |
3 |
0.0000 |
| 212 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 213 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 214 |
BACK PAIN |
3 |
0.0000 |
| 215 |
ARTHRITIS |
1 |
0.0000 |
| 216 |
THROMBOSIS |
1 |
0.0000 |
| 217 |
DRY MOUTH |
1 |
0.0000 |
| 218 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 219 |
FATIGUE |
9 |
0.0000 |
| 220 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 221 |
COVID-19 |
2 |
0.0000 |
| 222 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 223 |
ALOPECIA |
2 |
0.0000 |
| 224 |
SYNCOPE |
1 |
0.0000 |
| 225 |
FLUSHING |
1 |
0.0000 |
| 226 |
SINUSITIS |
1 |
0.0000 |
| 227 |
HAEMORRHAGE |
1 |
0.0000 |
| 228 |
DYSPNOEA |
5 |
0.0000 |
| 229 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 230 |
FEELING ABNORMAL |
2 |
0.0000 |
| 231 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 232 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 233 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 234 |
HYPERHIDROSIS |
1 |
0.0000 |
| 235 |
DRY SKIN |
1 |
0.0000 |
| 236 |
VISION BLURRED |
1 |
0.0000 |
| 237 |
ARTHRALGIA |
3 |
0.0000 |
| 238 |
INFECTION |
1 |
0.0000 |
| 239 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 240 |
PARAESTHESIA |
1 |
0.0000 |
| 241 |
PNEUMONIA |
2 |
0.0000 |
| 242 |
TREMOR |
1 |
0.0000 |
| 243 |
PYREXIA |
2 |
0.0000 |
| 244 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 245 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 246 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 247 |
ASTHENIA |
2 |
0.0000 |
| 248 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 249 |
ANAEMIA |
1 |
0.0000 |
| 250 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 251 |
HYPOTENSION |
1 |
0.0000 |
| 252 |
SOMNOLENCE |
1 |
0.0000 |
| 253 |
MALAISE |
2 |
0.0000 |
| 254 |
COUGH |
1 |
0.0000 |
| 255 |
ANXIETY |
1 |
0.0000 |
| 256 |
OFF LABEL USE |
3 |
0.0000 |
| 257 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 258 |
PAIN |
2 |
0.0000 |